 MIAMI, March 01, 2022 GLOBE NEWSWIRE -- Veru Inc. NASDAQ: VERU, an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancers, today announced that the Company will present at the Oppenheimer 32nd Annual Healthcare Conference. The presentation will be available through the Conference on March 15, 2022, at 11:20 am Eastern Time. 